Bioventus Inc. (BVS) Revenue History
Bioventus Inc. (BVS) annual revenue history. Get revenue data in Excel with MarketXLS.
Revenue Data
| Period | Revenue (USD) |
|---|---|
| 2021-12-31 | $430.90M |
| 2022-12-31 | $512.12M |
| 2023-12-31 | $512.35M |
| 2024-12-31 | $573.28M |
| 2025-12-31 | $568.09M |
How BVS compares with sector peers
| Symbol | Company | Revenue (latest fiscal year) |
|---|---|---|
| AXSM | Axsome Therapeutics Inc. | $638.50M |
| AZTA | Azenta Inc. | $593.82M |
| ATRC | AtriCure Inc. | $534.53M |
| VCYT | Veracyte Inc. | $517.14M |
| ADMA | ADMA Biologics Inc | $510.17M |
These are five companies in the same sector as BVS with a comparable annual revenue. Each figure above is that company's most recent completed fiscal year, read from the same annual statements as the table on its own page, so the period end dates can differ between rows.
Get Bioventus Inc. Data in Excel
Stream real-time stock prices and financials directly into your spreadsheets with MarketXLS.
Try: =hf_Revenue("BVS", 2024)
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Volume |
| 2 | BVS | $14.38 | +0.35% | 0.75M |
| 3 | ||||
| 4 | ||||
| 5 |